Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008US20080299614 Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters
12/04/2008US20080299612 Fusion proteins with cleavable spacers and uses thereof
12/04/2008US20080299611 Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins
12/04/2008US20080299610 Human toll homologue
12/04/2008US20080299599 Fluorescent proteins for monitoring intracellular superoxide production
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299591 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
12/04/2008US20080299586 Olfactory receptors for isolvaleric acid and related malodorants and use thereof in assays for identification of blockers
12/04/2008US20080299561 Novel therapeutic targets in cancer
12/04/2008US20080299548 polynucleotide having a homology of 95% or more with the polynucleotide specifically expressed in a mouse embryonic stem (ES) cell; used for the detection of an ES cell, screening for a somatic cell nuclear reprogramming substance, screening for a ES cell maintaining substance
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299546 Canine Cd20 Gene
12/04/2008US20080299544 Hcv Multiple Epitope Fusion Antigens With Modified Proteolytic Cleavage Sites And Uses Thereof
12/04/2008US20080299285 Process For The Preparation Of Ferri-Succinylcasein
12/04/2008US20080299282 Novel canola protein isolate
12/04/2008US20080299270 Fat Taste Receptors and Their Methods of Use
12/04/2008US20080299180 Peptides based on the sequence of human lactoferrin and their use
12/04/2008US20080299167 Vascular Endothelial Growth Factors And Methods Of Their Use
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299143 Cryptosporidium parvum antigens, antibodies thereof and diagnostic and therapeutic compositions thereof
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299139 Mammalian cytokines; related reagents and methods
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299111 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
12/04/2008US20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
12/04/2008US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
12/04/2008US20080299096 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (glp-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
12/04/2008US20080299085 Using fusion protein comprised of terminal reporter molecules to rapidly detect virus binding and entry into cells; receptor-dependent targeted therapy; viricides
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299082 Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299072 Chemokine Antagonists
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299045 Composition for Prevention, Treatment, and Diagnosis of Chronic Obstructive Pulmonary Disease (Copd)
12/04/2008US20080299042 Membrane Associated Molecules
12/04/2008US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
12/04/2008CA2692652A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
12/04/2008CA2689536A1 P53 peptide vaccine
12/04/2008CA2688714A1 Yield enhancement in plants by modulation of garp transcripton factor zmrr10_p
12/04/2008CA2688587A1 Nucleic acid and amino acid sequences, and vaccine to control sea lice infestations in fish
12/04/2008CA2688557A1 Fluorescent protein particles
12/04/2008CA2688543A1 Vegf-d mutants and their use
12/04/2008CA2688521A1 Fluorescent proteins and methods of use thereof
12/04/2008CA2688464A1 A process of aqueous protein extraction from brassicaceae oilseeds
12/04/2008CA2688417A1 Calcium channel proteins and uses thereof
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688284A1 Streptococcus pneumoniae pilus antigens
12/04/2008CA2688232A1 A method of enhancing recombinant protein production
12/04/2008CA2687990A1 Cross-linked collagen and uses thereof
12/04/2008CA2687908A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof
12/04/2008CA2687728A1 Mutated parvovirus structural proteins as vaccines
12/04/2008CA2687499A1 New indications for anti- il-i-beta therapy
12/04/2008CA2687211A1 Yield enhancement in plants by modulation of maize alfins
12/04/2008CA2686803A1 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
12/04/2008CA2686642A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
12/04/2008CA2679085A1 Hydrocarbon-producing genes and methods of their use
12/03/2008EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2008EP1998177A2 Compositions and methods for diagnosing and treating colon cancers
12/03/2008EP1997900A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/03/2008EP1997891A1 Generation and selection of recombinant varied binding proteins
12/03/2008EP1997890A1 Chinese hamster apoptosis-related genes
12/03/2008EP1997887A1 Multimer of extracellular domain of cell surface functional molecule
12/03/2008EP1997885A1 Fluorescent proteins and methods of use thereof
12/03/2008EP1997881A1 Tuberculosis vaccine
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1997828A2 Stabilized alpha helical peptides from BCL-2 and uses thereof
12/03/2008EP1997827A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them
12/03/2008EP1997514A1 High avidity polyvalent and polyspecific reagents
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997508A2 S-adenosyl homocysteinase (SAHH) as a therapeutic agent for cancer
12/03/2008EP1996947A1 Method for forming molecular sequences on surfaces
12/03/2008EP1996732A2 Mycobacterial disease detection, treatment, and drug discovery
12/03/2008EP1996721A2 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis
12/03/2008EP1996712A2 D-amino acid selection for soybean
12/03/2008EP1996707A2 A novel method of protecting islet cells from apoptosis during the donor harvesting process
12/03/2008EP1996618A1 Ammonia transporter gene and use thereof
12/03/2008EP1996617A2 Amylin derivatives
12/03/2008EP1996616A1 Truncated il-17ra soluble receptor and methods of using in inflammation
12/03/2008EP1996615A2 Broad spectrum antiviral compositions
12/03/2008EP1996614A1 Ctsp cancer-testis antigens
12/03/2008EP1996613A2 Muteins of tear lipocalin with affinity for the t-cell coreceptor cd4
12/03/2008EP1996612A1 Compositions for treatment of cancer
12/03/2008EP1996611A1 Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics
12/03/2008EP1996610A1 Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus
12/03/2008EP1996605A2 Protein folding
12/03/2008EP1996231A2 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
12/03/2008EP1996230A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
12/03/2008EP1996223A1 Acylated single chain insulin
12/03/2008EP1996186A2 A method for the preparation of recombinant human thrombin and fibrinogen
12/03/2008EP1838728A4 Human protooncogene and protein encoded therein
12/03/2008EP1784420B1 Degradable clostridial toxins
12/03/2008EP1776382B1 A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures
12/03/2008EP1641818B1 Polypeptides having binding affinity for her2
12/03/2008EP1613737A4 Artificial receptors including reversibly immobilized building blocks and methods
12/03/2008EP1575354B1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure, and applications thereof
12/03/2008EP1437365B1 Use of cardiotrophin in hepatic diseases
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 2916